LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article: Tumour vascularization: sprouting angiogenesis and beyond.

    Hillen, Femke / Griffioen, Arjan W

    Cancer metastasis reviews

    2007  Volume 26, Issue 3-4, Page(s) 489–502

    Abstract: Tumour angiogenesis is a fast growing domain in tumour biology. Many growth factors and mechanisms have been unravelled. For almost 30 years, the sprouting of new vessels out of existing ones was considered as an exclusive way of tumour vascularisation. ... ...

    Abstract Tumour angiogenesis is a fast growing domain in tumour biology. Many growth factors and mechanisms have been unravelled. For almost 30 years, the sprouting of new vessels out of existing ones was considered as an exclusive way of tumour vascularisation. However, over the last years several additional mechanisms have been identified. With the discovery of the contribution of intussusceptive angiogenesis, recruitment of endothelial progenitor cells, vessel co-option, vasculogenic mimicry and lymphangiogenesis to tumour growth, anti-tumour targeting strategies will be more complex than initially thought. This review highlights these processes and intervention as a potential application in cancer therapy. It is concluded that future anti-vascular therapies might be most beneficial when based on multimodal anti-angiogenic, anti-vasculogenic mimicry and anti-lymphangiogenic strategies.
    MeSH term(s) Animals ; Endothelial Cells/cytology ; Humans ; Lymphangiectasis ; Neoplasms/blood supply ; Neovascularization, Pathologic/etiology ; Stem Cells/physiology ; Vascular Endothelial Growth Factor A/physiology
    Chemical Substances Vascular Endothelial Growth Factor A
    Language English
    Publishing date 2007-12
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 604857-2
    ISSN 1573-7233 ; 0167-7659
    ISSN (online) 1573-7233
    ISSN 0167-7659
    DOI 10.1007/s10555-007-9094-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.

    Froyen, Guy / Broekmans, An / Hillen, Femke / Pat, Karin / Achten, Ruth / Mebis, Jeroen / Rummens, Jean-Luc / Willemse, Johan / Maes, Brigitte

    PloS one

    2016  Volume 11, Issue 4, Page(s) e0154038

    Abstract: The inevitable switch from standard molecular methods to next-generation sequencing for the molecular profiling of tumors is challenging for most diagnostic laboratories. However, fixed validation criteria for diagnostic accreditation are not in place ... ...

    Abstract The inevitable switch from standard molecular methods to next-generation sequencing for the molecular profiling of tumors is challenging for most diagnostic laboratories. However, fixed validation criteria for diagnostic accreditation are not in place because of the great variability in methods and aims. Here, we describe the validation of a custom panel of hotspots in 24 genes for the detection of somatic mutations in non-small cell lung carcinoma, colorectal carcinoma and malignant melanoma starting from FFPE sections, using 14, 36 and 5 cases, respectively. The targeted hotspots were selected for their present or future clinical relevance in solid tumor types. The target regions were enriched with the TruSeq approach starting from limited amounts of DNA. Cost effective sequencing of 12 pooled libraries was done using a micro flow cell on the MiSeq and subsequent data analysis with MiSeqReporter and VariantStudio. The entire workflow was diagnostically validated showing a robust performance with maximal sensitivity and specificity using as thresholds a variant allele frequency >5% and a minimal amplicon coverage of 300. We implemented this method through the analysis of 150 routine diagnostic samples and identified clinically relevant mutations in 16 genes including KRAS (32%), TP53 (32%), BRAF (12%), APC (11%), EGFR (8%) and NRAS (5%). Importantly, the highest success rate was obtained when using also the low quality DNA samples. In conclusion, we provide a workflow for the validation of targeted NGS by a custom-designed pan-solid tumor panel in a molecular diagnostic lab and demonstrate its robustness in a clinical setting.
    MeSH term(s) High-Throughput Nucleotide Sequencing ; Humans ; Limit of Detection ; Mutation ; Neoplasms/diagnosis ; Neoplasms/genetics ; Reproducibility of Results ; Sensitivity and Specificity
    Language English
    Publishing date 2016-04-21
    Publishing country United States
    Document type Journal Article ; Validation Studies
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0154038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project.

    Visser, Leonie N C / Pelt, Sophie A R / Kunneman, Marleen / Bouwman, Femke H / Claus, Jules J / Kalisvaart, Kees J / Hempenius, Liesbeth / de Beer, Marlijn H / Roks, Gerwin / Boelaarts, Leo / Kleijer, Mariska / van der Flier, Wiesje M / Smets, Ellen M A / Hillen, Marij A

    Health expectations : an international journal of public participation in health care and health policy

    2019  Volume 23, Issue 1, Page(s) 52–62

    Abstract: Background: The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer's disease (AD). Timely diagnosis may benefit patients by reducing their uncertainty regarding the cause of symptoms, yet does not always provide ... ...

    Abstract Background: The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer's disease (AD). Timely diagnosis may benefit patients by reducing their uncertainty regarding the cause of symptoms, yet does not always provide patients with the desired certainty.
    Objective: To examine, using both quantitative and qualitative methods, uncertainty communicated by memory clinic clinicians in post-diagnostic testing consultations with patients and their caregivers.
    Methods: First, we identified all uncertainty expressions of 22 clinicians in audiotaped post-diagnostic testing consultations with 78 patients. Second, we statistically explored relationships between patient/clinician characteristics and uncertainty expressions. Third, the transcribed uncertainty expressions were qualitatively analysed, determining the topic to which they pertained, their source and initiator/elicitor (clinicians/patients/caregivers).
    Results: Within 57/78 (73%) consultations, clinicians expressed in total 115 uncertainties, of which 37% elicited by the patient or caregiver. No apparent relationships were found between patient/clinician characteristics and whether or not, and how often clinicians expressed uncertainty. Uncertainty expressions pertained to ten different topics, most frequently patient's diagnosis and symptom progression. Expressed uncertainty was mostly related to the unpredictability of the future and limits to available knowledge.
    Discussion and conclusions: The majority of clinicians openly discussed the limits of scientific knowledge and diagnostic testing with patients and caregivers in the dementia context. Noticeably, clinicians did not discuss uncertainty in about one quarter of consultations. More evidence is needed on the beneficial and/or harmful effects on patients of discussing uncertainty with them. This knowledge can be used to support clinicians to optimally convey uncertainty and facilitate patients' uncertainty management.
    MeSH term(s) Aged ; Alzheimer Disease/diagnosis ; Ambulatory Care Facilities ; Caregivers/psychology ; Communication ; Diagnostic Tests, Routine ; Disclosure ; Female ; Health Personnel/statistics & numerical data ; Humans ; Male ; Middle Aged ; Netherlands ; Patients/psychology ; Patients/statistics & numerical data ; Qualitative Research ; Uncertainty
    Language English
    Publishing date 2019-10-22
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2119434-8
    ISSN 1369-7625 ; 1369-6513
    ISSN (online) 1369-7625
    ISSN 1369-6513
    DOI 10.1111/hex.12964
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.

    Guy Froyen / An Broekmans / Femke Hillen / Karin Pat / Ruth Achten / Jeroen Mebis / Jean-Luc Rummens / Johan Willemse / Brigitte Maes

    PLoS ONE, Vol 11, Iss 4, p e

    2016  Volume 0154038

    Abstract: The inevitable switch from standard molecular methods to next-generation sequencing for the molecular profiling of tumors is challenging for most diagnostic laboratories. However, fixed validation criteria for diagnostic accreditation are not in place ... ...

    Abstract The inevitable switch from standard molecular methods to next-generation sequencing for the molecular profiling of tumors is challenging for most diagnostic laboratories. However, fixed validation criteria for diagnostic accreditation are not in place because of the great variability in methods and aims. Here, we describe the validation of a custom panel of hotspots in 24 genes for the detection of somatic mutations in non-small cell lung carcinoma, colorectal carcinoma and malignant melanoma starting from FFPE sections, using 14, 36 and 5 cases, respectively. The targeted hotspots were selected for their present or future clinical relevance in solid tumor types. The target regions were enriched with the TruSeq approach starting from limited amounts of DNA. Cost effective sequencing of 12 pooled libraries was done using a micro flow cell on the MiSeq and subsequent data analysis with MiSeqReporter and VariantStudio. The entire workflow was diagnostically validated showing a robust performance with maximal sensitivity and specificity using as thresholds a variant allele frequency >5% and a minimal amplicon coverage of 300. We implemented this method through the analysis of 150 routine diagnostic samples and identified clinically relevant mutations in 16 genes including KRAS (32%), TP53 (32%), BRAF (12%), APC (11%), EGFR (8%) and NRAS (5%). Importantly, the highest success rate was obtained when using also the low quality DNA samples. In conclusion, we provide a workflow for the validation of targeted NGS by a custom-designed pan-solid tumor panel in a molecular diagnostic lab and demonstrate its robustness in a clinical setting.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2016-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic

    Leonie N. C. Visser / Sophie A. R. Pelt / Marleen Kunneman / Femke H. Bouwman / Jules J. Claus / Kees J. Kalisvaart / Liesbeth Hempenius / Marlijn H. deBeer / Gerwin Roks / Leo Boelaarts / Mariska Kleijer / Wiesje M. van derFlier / Ellen M. A. Smets / Marij A. Hillen

    Health Expectations, Vol 23, Iss 1, Pp 52-

    The ABIDE project

    2020  Volume 62

    Abstract: Abstract Background The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer's disease (AD). Timely diagnosis may benefit patients by reducing their uncertainty regarding the cause of symptoms, yet does not always provide ... ...

    Abstract Abstract Background The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer's disease (AD). Timely diagnosis may benefit patients by reducing their uncertainty regarding the cause of symptoms, yet does not always provide patients with the desired certainty. Objective To examine, using both quantitative and qualitative methods, uncertainty communicated by memory clinic clinicians in post‐diagnostic testing consultations with patients and their caregivers. Methods First, we identified all uncertainty expressions of 22 clinicians in audiotaped post‐diagnostic testing consultations with 78 patients. Second, we statistically explored relationships between patient/clinician characteristics and uncertainty expressions. Third, the transcribed uncertainty expressions were qualitatively analysed, determining the topic to which they pertained, their source and initiator/elicitor (clinicians/patients/caregivers). Results Within 57/78 (73%) consultations, clinicians expressed in total 115 uncertainties, of which 37% elicited by the patient or caregiver. No apparent relationships were found between patient/clinician characteristics and whether or not, and how often clinicians expressed uncertainty. Uncertainty expressions pertained to ten different topics, most frequently patient's diagnosis and symptom progression. Expressed uncertainty was mostly related to the unpredictability of the future and limits to available knowledge. Discussion and conclusions The majority of clinicians openly discussed the limits of scientific knowledge and diagnostic testing with patients and caregivers in the dementia context. Noticeably, clinicians did not discuss uncertainty in about one quarter of consultations. More evidence is needed on the beneficial and/or harmful effects on patients of discussing uncertainty with them. This knowledge can be used to support clinicians to optimally convey uncertainty and facilitate patients' uncertainty management.
    Keywords Alzheimer's disease ; dementia ; diagnostic work‐up ; memory clinic ; physician‐patient communication ; uncertainty ; Medicine (General) ; R5-920 ; Public aspects of medicine ; RA1-1270
    Subject code 170
    Language English
    Publishing date 2020-02-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Prognostic role of vasculogenic mimicry in colorectal cancer.

    Baeten, Coen I M / Hillen, Femke / Pauwels, Patrick / de Bruine, Adriaan P / Baeten, Cor G M I

    Diseases of the colon and rectum

    2009  Volume 52, Issue 12, Page(s) 2028–2035

    Abstract: Purpose: Angiogenesis, as measured by degree of microvessel density, has been associated with tumor progression in many tumor types but does not always correlate with clinical outcome. In 1999, aggressive tumor cells were shown to form blood-conducting ... ...

    Abstract Purpose: Angiogenesis, as measured by degree of microvessel density, has been associated with tumor progression in many tumor types but does not always correlate with clinical outcome. In 1999, aggressive tumor cells were shown to form blood-conducting tubes not lined by endothelial cells, and this phenomenon was termed vasculogenic mimicry. We investigated angiogenesis and the presence of vasculogenic mimicry in colorectal carcinoma in relation to tumor stage, patient survival, and genetic indicators of tumor cell plasticity.
    Methods: Paraffin-embedded tissue samples were examined from a study of 117 patients with colorectal carcinoma with a 12-year follow-up. Immunohistochemical analysis was used to measure microvessel density and proliferating endothelial cells and to detect vasculogenic mimicry (scored by 3 independent observers). Cell cultures from 7 colon cell lines, real-time polymerase chain reaction (PCR) on cell lines, frozen tissue material from 4 colorectal cancer patients with and 4 without vasculogenic mimicry, and fresh colorectal cancer tissue from 2 patients were used to investigate the relationship between vasculogenic mimicry and tumor cell plasticity.
    Results: Microvessel density was not a prognostic marker in our patients. We found vasculogenic mimicry in 23 (19.7%) of 117 colorectal tumor samples. Cell culture experiments and real-time PCR on human colorectal carcinoma material showed evidence for vasculogenic mimicry with overexpression of EPHA2 and LAMC2, known to be important for the tube-forming capacity of melanoma tumor cells. The presence of vasculogenic mimicry was associated with significantly shortened survival, both overall (P < 0.0001) and within intermediate cancer stages (Dukes B, P = 0.0277; Dukes C, P < 0.0001).
    Conclusions: Vasculogenic mimicry can occur in colorectal carcinoma and appears to be comparable to vasculogenic mimicry described in other tumors. Moreover, vasculogenic mimicry in colorectal carcinoma may be a strong independent prognostic marker for survival.
    MeSH term(s) Adenocarcinoma/blood supply ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms/blood supply ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Female ; Gene Expression ; Humans ; Laminin/genetics ; Male ; Microvessels/pathology ; Middle Aged ; Neovascularization, Pathologic/diagnosis ; Neovascularization, Pathologic/pathology ; Prognosis ; Receptor, EphA2/genetics ; Tumor Cells, Cultured
    Chemical Substances LAMC2 protein, human ; Laminin ; Receptor, EphA2 (EC 2.7.10.1)
    Language English
    Publishing date 2009-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 212581-x
    ISSN 1530-0358 ; 0012-3706
    ISSN (online) 1530-0358
    ISSN 0012-3706
    DOI 10.1007/DCR.0b013e3181beb4ff
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.

    van der Kroef, Maarten / van den Hoogen, Lucas L / Mertens, Jorre S / Blokland, Sofie L M / Haskett, Scott / Devaprasad, Abhinandan / Carvalheiro, Tiago / Chouri, Eleni / Vazirpanah, Nadia / Cossu, Marta / Wichers, Catherina G K / Silva-Cardoso, Sandra C / Affandi, Alsya J / Bekker, Cornelis P J / Lopes, Ana P / Hillen, Maarten R / Bonte-Mineur, Femke / Kok, Marc R / Beretta, Lorenzo /
    Rossato, Marzia / Mingueneau, Michaël / van Roon, Joel A G / Radstake, Timothy R D J

    European journal of immunology

    2019  Volume 50, Issue 1, Page(s) 119–129

    Abstract: Systemic sclerosis (SSc), systemic lupus erythematosus (SLE) and primary Sjögrens syndrome (pSS) are clinically distinct systemic autoimmune diseases (SADs) that share molecular pathways. We quantified the frequency of circulating immune-cells in 169 ... ...

    Abstract Systemic sclerosis (SSc), systemic lupus erythematosus (SLE) and primary Sjögrens syndrome (pSS) are clinically distinct systemic autoimmune diseases (SADs) that share molecular pathways. We quantified the frequency of circulating immune-cells in 169 patients with these SADs and 44 healty controls (HC) using mass-cytometry and assessed the diagnostic value of these results. Alterations in the frequency of immune-cell subsets were present in all SADs compared to HC. Most alterations, including a decrease of CD56
    MeSH term(s) Adult ; Aged ; Female ; Flow Cytometry/methods ; Humans ; Lupus Erythematosus, Systemic/diagnosis ; Lupus Erythematosus, Systemic/immunology ; Male ; Middle Aged ; Phenotype ; Scleroderma, Systemic/diagnosis ; Scleroderma, Systemic/immunology ; Sjogren's Syndrome/diagnosis ; Sjogren's Syndrome/immunology
    Language English
    Publishing date 2019-09-11
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.201948129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma.

    Hillen, Femke / van de Winkel, Anouk / Creytens, David / Vermeulen, Anton H M / Griffioen, Arjan W

    Melanoma research

    2006  Volume 16, Issue 5, Page(s) 453–457

    Abstract: The induction of angiogenesis is crucial in the development of most human tumors. Angiogenesis is routinely assessed by the density of tumor microvessels. This technique reveals controversial results on the clinical and prognostic value of angiogenesis ... ...

    Abstract The induction of angiogenesis is crucial in the development of most human tumors. Angiogenesis is routinely assessed by the density of tumor microvessels. This technique reveals controversial results on the clinical and prognostic value of angiogenesis in melanoma. We investigated angiogenesis in tumor tissues of 58 cutaneous melanoma patients, of which a clinical follow-up of over 10 years was available, through assessment of microvessel density and by enumeration of the number of proliferating endothelial cells. To that end, vessels were immunohistochemically detected by CD31/CD34 staining, and proliferating endothelial cells were enumerated in a double staining with the proliferation marker Ki67. We found that microvessel density did not correlate with tumor stage or survival, neither in intratumoral nor in peritumoral areas. In contrast, proliferating endothelial cells were only observed in intratumoral areas and were correlated positively with tumor stage and the presence of distant metastases. In addition, a strong positive correlation was found with the number of proliferating tumor cells. Finally, high numbers of growing endothelial cells predicted short survival. Our results show that angiogenesis could best be measured by enumeration of proliferating endothelial cells and that this parameter has prognostic value in patients with cutaneous melanoma.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Antigens, CD34/biosynthesis ; Cell Proliferation ; Cells, Cultured ; Endothelium, Vascular/cytology ; Female ; Humans ; Ki-67 Antigen/biosynthesis ; Male ; Melanoma/diagnosis ; Melanoma/metabolism ; Melanoma/pathology ; Microcirculation/metabolism ; Middle Aged ; Platelet Endothelial Cell Adhesion Molecule-1/biosynthesis ; Skin Neoplasms/diagnosis ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology
    Chemical Substances Antigens, CD34 ; Ki-67 Antigen ; Platelet Endothelial Cell Adhesion Molecule-1
    Language English
    Publishing date 2006-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 1095779-0
    ISSN 1473-5636 ; 0960-8931
    ISSN (online) 1473-5636
    ISSN 0960-8931
    DOI 10.1097/01.cmr.0000232291.68666.4c
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: A transgenic Tie2-GFP athymic mouse model; a tool for vascular biology in xenograft tumors.

    Hillen, Femke / Kaijzel, Eric L / Castermans, Karolien / oude Egbrink, Mirjam G A / Löwik, Clemens W G M / Griffioen, Arjan W

    Biochemical and biophysical research communications

    2008  Volume 368, Issue 2, Page(s) 364–367

    Abstract: We report the generation of a transgenic Tie2-GFP athymic nude mouse, carrying green fluorescent blood vessels throughout the body. This transgenic mouse is a tool for studies in vascular biology, and is especially of interest for imaging of tumor ... ...

    Abstract We report the generation of a transgenic Tie2-GFP athymic nude mouse, carrying green fluorescent blood vessels throughout the body. This transgenic mouse is a tool for studies in vascular biology, and is especially of interest for imaging of tumor angiogenesis and the study of anti-angiogenesis strategies in (human) xenografts. Intravital microscopy identified the presence of blood conducting structures that are not lined by endothelial cells. Dedifferentiation of aggressive tumor cells can lead to acquisition of endothelial characteristics. This process of tumor cell plasticity, also referred to as vasculogenic mimicry, has been suggested to contribute to the circulatory system in a tumor. In plastic EW7 Ewing sarcoma tumors in these Tie2-GFP mice, we observed blood flow in both regular blood vessels and non-fluorescent tumor cell-lined channels, visualizing in vivo hemodynamics in vasculogenic channels. These results demonstrate that the transgenic Tie2-GFP athymic mouse model is a valuable tool for vascular biology research.
    MeSH term(s) Animals ; Disease Models, Animal ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Mice, Transgenic ; Microscopy, Fluorescence/methods ; Molecular Probe Techniques ; Neoplasms/blood supply ; Neoplasms/metabolism ; Neoplasms/pathology ; Neovascularization, Pathologic/metabolism ; Neovascularization, Pathologic/pathology ; Receptor, TIE-2/genetics ; Receptor, TIE-2/metabolism
    Chemical Substances Receptor, TIE-2 (EC 2.7.10.1)
    Language English
    Publishing date 2008-04-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2008.01.080
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer.

    Baeten, Coen I M / Castermans, Karolien / Lammering, Guido / Hillen, Femke / Wouters, Bradly G / Hillen, Harry F P / Griffioen, Arjan W / Baeten, Cornelius G M I

    International journal of radiation oncology, biology, physics

    2006  Volume 66, Issue 4, Page(s) 1219–1227

    Abstract: Background: We and others have shown that angiogenesis and leukocyte infiltration are important prognostic factors in rectal cancer. However, little is known about its possible changes in response to radiotherapy (RTX), which is frequently given to ... ...

    Abstract Background: We and others have shown that angiogenesis and leukocyte infiltration are important prognostic factors in rectal cancer. However, little is known about its possible changes in response to radiotherapy (RTX), which is frequently given to rectal tumors as a neoadjuvant treatment to improve the prognosis. We therefore investigated the biologic effects of RTX on these parameters using fresh-frozen biopsy samples of tumor and normal mucosa tissue before and after RTX.
    Methods: Biopsy samples were taken from a total of 34 patients before and after either a short course or long course of RTX combined with chemotherapy. The following parameters were analyzed by immunohistochemistry, flow cytometry, or quantitative real-time polymerase chain reaction: Microvessel density, leukocyte infiltration, proliferating epithelial and tumor cells, proliferating endothelial cells, adhesion molecule expression on endothelial cells, and the angiogenic mRNA profile.
    Results: The tumor biopsy samples taken after RTX treatment demonstrated a significant decrease in microvessel density and the number of proliferating tumor cells and proliferating endothelial cells (p < 0.001). In contrast, the leukocyte infiltration, the levels of basic fibroblast growth factor in carcinoma tissue, and the adhesion molecule expression on endothelial cells in normal as well as carcinoma tissue increased significantly (p < 0.05).
    Conclusion: Our data show that together with an overall decrease in tumor cell and endothelial cell proliferation, RTX results in an increase in the expression of adhesion molecules that stimulate leukocyte infiltration. This suggests the possibility that, in addition to its direct cytotoxic effect, radiation may also stimulate an immunologic tumor response that could contribute to the documented improvement in local tumor control and distal failure rate of rectal cancers.
    MeSH term(s) Aged ; Drug Therapy ; Female ; Humans ; Leukocytes/pathology ; Male ; Neovascularization, Pathologic/pathology ; Neovascularization, Pathologic/prevention & control ; Radiotherapy ; Rectal Neoplasms/blood supply ; Rectal Neoplasms/pathology ; Rectal Neoplasms/therapy
    Language English
    Publishing date 2006-11-15
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 197614-x
    ISSN 1879-355X ; 0360-3016
    ISSN (online) 1879-355X
    ISSN 0360-3016
    DOI 10.1016/j.ijrobp.2006.07.1362
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top